Advertisement
Advertisement
AKTX
Akari Therapeutics plc ADR (0.01 USD)
10.10
USDSponsored
-0.02
-0.25%
Sep 17, 12:35 UTC -4
Open
AKTX Earnings Reports
Positive Surprise Ratio
AKTX beat 9 of 20 last estimates.
45%
Next Report
Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$2.13
Implied change from Q2 26 (Revenue/ EPS)
--
/-20.52%
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Akari Therapeutics plc ADR (0.01 USD) earnings per share and revenue
On Aug 13, 2026, AKTX reported earnings of -2.68 USD per share (EPS) for Q2 26, missing the estimate of -1.30 USD, resulting in a -105.27% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.71% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -2.13 USD, with revenue projected to reach -- USD, implying an decrease of -20.52% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
FAQ
What were Akari Therapeutics plc ADR (0.01 USD)'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Akari Therapeutics plc ADR (0.01 USD) reported EPS of -$2.68, missing estimates by -105.27%, and revenue of $0.00, 0% as expectations.
How did the market react to Akari Therapeutics plc ADR (0.01 USD)'s Q2 2026 earnings?
The stock price moved up 7.71%, changed from $7.00 before the earnings release to $7.54 the day after.
When is Akari Therapeutics plc ADR (0.01 USD) expected to report next?
The next earning report is scheduled for Nov 11, 2026.
What are the forecasts for Akari Therapeutics plc ADR (0.01 USD)'s next earnings report?
Based on 4
analysts, Akari Therapeutics plc ADR (0.01 USD) is expected to report EPS of -$2.13 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.